Form 4: Cutera Inc. Executive Michael Karavitis Reports Changes in Beneficial Ownership

EVP and Chief Technology Officer of Cutera Inc., Michael Karavitis, reports the withholding of shares for tax liabilities and the acquisition of stock options.

Summary

• Michael Karavitis, EVP and Chief Technology Officer of Cutera Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 13, 2024, 769 shares of common stock were withheld to settle tax liabilities related to the vesting of 2,086 Restricted Stock Units at a price of $2.23 per share.
• Also on May 13, 2024, Karavitis acquired 55,000 stock options with an exercise price of $2.23, vesting monthly from April 25, 2024, and expiring on May 13, 2031, subject to continued service with the company.
• Following these transactions, Karavitis beneficially owns 70,916 shares of common stock and 125,704 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating standard executive compensation practices. The stock option grant suggests a degree of confidence, but it's not overtly positive or negative.

Positives

• The acquisition of 55,000 stock options indicates confidence in the company's future performance by the executive.
• The vesting schedule of the stock options (monthly from April 25, 2024) incentivizes continued service and contribution to the company.

Risks

• The expiration of stock options is contingent upon continued service with the company, creating a potential risk if the executive's employment terminates.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the stock options suggests an expectation of continued service and contribution from the executive.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the technology and medical device industries, used to align management's interests with those of shareholders.
• Vesting schedules, such as the 1/48 per month structure, are typical for incentivizing long-term commitment.
• Comparing the size of the option grant and the executive's existing holdings to those of peers at similar companies (e.g., laser and energy-based device companies like Cynosure, Lumenis, or Candela) would provide further context.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see the executive's continued investment in the company as a sign of stability and confidence in the future.

Key Dates

Keywords

Form 4, beneficial ownership, stock options, restricted stock units, Cutera Inc., Karavitis, CUTR, executive compensation